Valeri A, Radhakrishnan J, Vernocchi L, Carmichael L D, Stern L
Department of Medicine (Renal Division), Columbia-Presbyterian Medical Center, New York, NY 10032.
Am J Kidney Dis. 1993 Mar;21(3):300-9. doi: 10.1016/s0272-6386(12)80750-5.
We performed a prospective study to examine the epidemiology and microbiology of peritonitis complicating acute intermittent peritoneal dialysis (IPD) performed in an in-hospital setting for the management of acute and chronic renal failure and to see the effect of a closed-drainage system on altering the frequency and cause of peritonitis. Over a 15-month period, 79 patients were treated with acute IPD for a total of 136 treatments each ranging in length from 2 to 40 days (median, 4 days). The majority of cases had acute renal failure (ARF; 65%) and were treated in intensive care units (ICUs; 74%) with serious comorbid conditions (60%). About half were treated with a two-bag, ventable (open)-drainage system with unprotected spikes, and the other half were treated with a single-bag, spike-protected, closed-drainage system. There were 27 cases of peritonitis for a rate of 4.5 cases/100 patient-days at risk. About half were gram-positive infections; the remainder were gram-negative or mixed (25%) or Candida sp (25%). The use of a closed-drainage system reduced the incidence of system-related peritonitis from 3.6 to 1.5 cases/100 patient-days. There was a high rate of peritonitis in the first 48 hours of treatment, which fell to a low stable rate thereafter and remained so for up to 15 days of continuous IPD. The use of a closed-drainage system eliminated the early (< 48 hours) high rate of peritonitis and maintained a low constant rate of peritonitis throughout treatment. There was an association of ARF and severe comorbid disease with more virulent organisms (gram-negative, mixed, and Candida sp), which, in turn, were both associated with antecedent broad-spectrum antibiotic therapy. Random positive surveillance cultures showed a frequency distribution similar to that of peritonitis cases over the duration of treatment, but with less virulent organisms. Peritonitis in acute IPD occurs when large or repeated inocula of organisms from the prevailing flora overwhelm the peritoneal immune clearance mechanisms. Prolonged courses of broad-spectrum antibiotic therapy provide no protection, but shift the resulting infecting flora toward more virulent pathogens. A closed-drainage system provides one method to reduce the frequency of peritoneal contamination.
我们进行了一项前瞻性研究,以调查在医院环境中进行急性间歇性腹膜透析(IPD)治疗急性和慢性肾衰竭时并发腹膜炎的流行病学和微生物学情况,并观察封闭引流系统对改变腹膜炎发生率和病因的影响。在15个月的时间里,79例患者接受了急性IPD治疗,共进行了136次治疗,每次治疗时长从2天至40天不等(中位数为4天)。大多数病例为急性肾衰竭(ARF;65%),并在重症监护病房(ICU;74%)接受治疗,伴有严重合并症(60%)。约一半患者采用双袋、可排气(开放)引流系统且穿刺针无保护装置进行治疗,另一半患者采用单袋、穿刺针有保护装置的封闭引流系统进行治疗。发生了27例腹膜炎,发生率为4.5例/100患者日。约一半为革兰氏阳性菌感染;其余为革兰氏阴性菌或混合菌感染(25%)或念珠菌属感染(25%)。使用封闭引流系统使与系统相关的腹膜炎发生率从3.6例/100患者日降至1.5例/100患者日。治疗的前48小时腹膜炎发生率较高,此后降至低水平并保持稳定,持续IPD长达15天期间均如此。使用封闭引流系统消除了早期(<48小时)腹膜炎的高发生率,并在整个治疗过程中维持了低且恒定的腹膜炎发生率。ARF和严重合并症与更具毒性的微生物(革兰氏阴性菌、混合菌和念珠菌属)相关,而这些微生物又都与先前的广谱抗生素治疗有关。随机阳性监测培养显示,在治疗期间其频率分布与腹膜炎病例相似,但微生物毒性较低。急性IPD中的腹膜炎是由于来自优势菌群的大量或反复接种微生物超过了腹膜免疫清除机制所致。长期使用广谱抗生素治疗并不能提供保护,反而会使最终感染菌群转向更具毒性的病原体。封闭引流系统提供了一种降低腹膜污染频率的方法。